Ligand Pharmaceuticals (LGND) Non Operating Interest Expenses (2010 - 2026)
Ligand Pharmaceuticals (LGND) recorded Non Operating Interest Expenses of $1.75 million in Q2 2026, up 51.6% from $1.15 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
On a TTM basis, Ligand Pharmaceuticals' Non Operating Interest Expenses came in at $6.19 million as of Jun 30, 2026, up 69.9% year-over-year; for FY2025, it came in at $4.72 million, up 55.3% from FY2024.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -29.7% (FY2020 to FY2025).
- Across earlier years, Non Operating Interest Expenses came in at $3.04 million in FY2024 (+363.0%), $656,000 in FY2023 (-63.5%), $1.8 million in FY2022 (-90.8%) and $19.62 million in FY2021 (-28.4%).
- Quarterly Non Operating Interest Expenses has ranged from $1,000 in Q3 2023 to $4.47 million in Q4 2021 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses has increased for four consecutive quarters, with growth averaging 194.0% over the last seven quarters.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 574.0% in Q4 2024, against a decline of 99.7% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.75 million (Q1 2026), $1.79 million (Q4 2025) and $910,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.03 Bn | 2.50 Bn | - | 1.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 883,000.00 |
| Sep 30, 2024 | 741,000.00 |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | 240,000.00 |
| Dec 31, 2022 | 240,000.00 |
| Sep 30, 2022 | 332,000.00 |
| Jun 30, 2022 | 438,000.00 |
| Mar 31, 2022 | 789,000.00 |
| Dec 31, 2021 | 4.47 Mn |
| Sep 30, 2021 | 4.44 Mn |
API Access
Ligand Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();